Thursday, 02 April 2020

Australia News

  • Protagonist, Ironwood expand peptide R&D deal

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2012

    Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging Protagonist's proprietary disulfide‐rich pep...Read more

  • Luminex restructures, shuts down Australian office

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

    Singapore: Luminex entered a restructuring plan focused on its assay and related products (ARP) segment's newborn screening group and has decided to shut down its Brisbane office in Austral...Read more

  • Lonza produces Bionomics' stem cell cancer drug

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2013

    Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies. Lonza will manufacture BNC1...Read more

  • Irish firm's track-&-trace system to curb fake drugs

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Horizon, an Irish engineerng consultancy firm, has completed testing of its new tracking system that aims at eliminating the use of counterfeit drugs. Leading the battle against...Read more

  • iSonea launches asthma monitoring device in Australia

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Sep, 2013

    Singapore: Australian medical technology company, iSonea, launched AirSonea wheeze monitoring device, in the Australian market. The device is intended for people, who are diagnosed with ast...Read more

  • Will the next blockbuster emerge from Asia?

    Australia |  Opinion | By Nandita Singh | 0 Comment | 17 Oct, 2012

    Blockbusters and super profits. Will the bioscience industry in this decade see these words come to life? More importantly, will these new examples emerge from companies in Asia? Two years...Read more

  • One compound to kill all known malarial strains

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: A recently discovered compound from the aminopyridine class could be a potential single-dose cure for all strains of malaria. The compound might also be able to block transmissio...Read more

  • Bionomics seeks $4.2 mn R&D tax incentive

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

    Singapore: Bionomics has lodged its FY 2012 tax return and registered with AusIndustry (on behalf of Innovation Australia) for the Australian R&D tax incentive. Bionomics anticipates t...Read more

  • Indian, Australian science academies sign MoU

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

    Singapore: The Australian Academy of Science (AAS) and Indian National Academy of Science (INAS) renewed their commitment to work more closely together. Professor Suzanne Cory, president,...Read more

  • Bionomics acquires US cancer firm

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    Singapore: Adelaide-based biotechnology company Bionomics has strengthened its presence in the US with the acquisition of a private biotechnology company Eclipse Therapeutics. The company a...Read more

  • Hettich, LBT form landmark bio-software JV

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Medical technology company, LBT Innovations, signed a landmark agreement with Switzerland-based laboratory instrumentation company Hettich, to establish a joint venture to drive ...Read more

  • Spinifex phase II postherpetic neuralgia trial is a success

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, revealed positive headline results from the phase II clinical trial of its lead product, EMA401, in posth...Read more

  • Australia is 3rd largest in terms of total company revenues

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2013

    Australia emerged as the third largest country in terms of the total revenue generated by companies during the calendar year 2012 in the recent BioSpectrum Asia Top 20 Survey. It leveraged ...Read more

  • Real-Time Location Systems are a big hit in Asia

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Rising costs are compelling hospitals in South East Asia, Australia and New Zealand (ANZ) to streamline their operations, which, in turn, is opening up several opportunities for ...Read more

  • Genetic Technologies gets US patent update

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: The US patent and trademark office (US PTO) has issued an action reaffirming the validity of certain claims contained in the Genetic Technologies' US Patent No. 5,612,179 (the '1...Read more

  • Japanese I'rom acquires 18% in Australian IDT

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 May, 2013

    Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the Tokyo Stock Exchange and is one of the leading providers of site manag...Read more

  • Nancy Millis - 'First Lady' of Australian biotech - passes away

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: Eminent Australian microbiologist Emeritus Professor Nancy Millis AC, who served as the chancellor of La Trobe University for 14 years, passed away on September 29, 2012. Also kn...Read more

  • Prima recruits patients for cancer vaccine trial

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

    Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. Prima has authorized several centers in Ukraine to start enrolling pat...Read more